Brief: Argenica Therapeutics Says FDA Grants Argenica Rare Pediatric Disease Designation For Arg-007
25/03/2024 01:02
March 25 (Reuters) - Argenica Therapeutics Ltd AGN.AX :
* U.S. FDA GRANTS ARGENICA RARE PEDIATRIC DISEASE
DESIGNATION FOR
ARG-007 IN TREATMENT OF HIE
Source text for Eikon: ID:nASX4RWVKS
Further company coverage: AGN.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Argenica Therapeutics
See all newsBrief: Argenica Therapeutics Says IND Application Advanced With Successful Completion Of Assay
Brief: Argenica Therapeutics Says Dianne Angus To Step Down As Non-Executive Chair
Australia's Argenica Therapeutics jumps on meeting FDA condition
Brief: Argenica Therapeutics Seeks Trading Halt
Brief: Argenica Therapeutics Gets Non-Dilutive Funding Up To A Total Of A$1.5M